Ranbaxy Launches Evoxac AG

Ranbaxy has begun marketing an authorized generic of Daiichi Sankyo’s dry-mouth treatment Evoxac in the U.S. per an agreement with the Japanese drugmaker. A generic version of Evoxac (cevimeline HCl) was also brought to market by Apotex this quarter following a patent settlement with Daiichi.
Generic Line